نتایج جستجو برای: peptide vaccine

تعداد نتایج: 263016  

Journal: :Molecular & Cellular Proteomics 2021

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 1999
F Wang E Bade C Kuniyoshi L Spears G Jeffery V Marty S Groshen J Weber

Twenty-five patients with high-risk resected stages IIB, III, and IV melanoma were immunized with a vaccine consisting of the minimal epitope, immunodominant 9-amino acid peptide derived from the MART-1 tumor antigen (AAGIGILTV) complexed with incomplete Freund's adjuvant. The last three patients received the MART-1(27-35) peptide with incomplete Freund's adjuvant mixed with CRL 1005, a block c...

2015
Shinjiro Sakamoto Satoko Matsueda Shinzo Takamori Uhi Toh Masanori Noguchi Shigeru Yutani Akira Yamada Shigeki Shichijo Teppei Yamada Shigetaka Suekane Kouichiro Kawano Tetsuro Sasada Noboru Hattori Nobuoki Kohno Kyogo Itoh

To develop a peptide vaccine for cancer patients with the HLA-A26 allele, which is a minor population worldwide, we investigated the immunological responses of HLA-A26(+) /A26(+) cancer patients to four different CTL epitope peptides under personalized peptide vaccine regimens. In personalized peptide vaccine regimens, two to four peptides showing positive peptide-specific IgG responses in pre-...

Bahman Khalesi, Fateme Sefid, Maysam Mard-Soltani, Zahra Payandeh,

Introduction: Vaccine studies against Pseudomonas aeruginosa have often focused on outer membrane proteins (OPRs) due to their potent stimulation of the immune response. Using major outer membrane proteins of cell walls (mOMPs) of P. aeruginosa and other Gram-negative bacteria actively stimulate the immune system without any toxic side effects. Moreover, these antigens show immunological cross-...

Background and Aims: Influenza vaccine production process is time-consuming with little-to-no cross-protection which requires annual adjustment. The construction of a universal vaccine to deal with the pandemics and epidemics which occasionally threat human population is the aim of many researches worldwide. Today, influenza vaccines are mostly against two major antigenic proteins, hemagglutini...

2016
Andrew Fiore-Gartland Bryce A. Manso David P. Friedrich Erin E. Gabriel Greg Finak Zoe Moodie Tomer Hertz Stephen C. De Rosa Nicole Frahm Peter B. Gilbert M. Juliana McElrath Shan Lu

The interferon gamma, enzyme-linked immunospot (IFN-γ ELISpot) assay is widely used to identify viral antigen-specific T cells is frequently employed to quantify T cell responses in HIV vaccine studies. It can be used to define T cell epitope specificities using panels of peptide antigens, but with sample and cost constraints there is a critical need to improve the efficiency of epitope mapping...

Journal: :Bioorganic & medicinal chemistry 2014
Fazren Azmi Abdullah Al Hadi Ahmad Fuaad Ashwini Kumar Giddam Michael R Batzloff Michael F Good Mariusz Skwarczynski Istvan Toth

Peptides are of great interest to be used as vaccine antigens due to their safety, ease of manufacturing and specificity in generating immune response. There have been massive discoveries of peptide antigens over the past decade. However, peptides alone are poorly immunogenic, which demand co-administration with strong adjuvant to enhance their immunogenicity. Recently, fibril-forming peptides ...

Journal: :Nucleic Acids Research 2005
Pedro A. Reche Ellis L. Reinherz

Prediction of peptide binding to major histocompatibility complex (MHC) molecules is a basis for anticipating T-cell epitopes, as well as epitope discovery-driven vaccine development. In the human, MHC molecules are known as human leukocyte antigens (HLAs) and are extremely polymorphic. HLA polymorphism is the basis of differential peptide binding, until now limiting the practical use of curren...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید